STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
DelistingApr 17, 2026, 04:07 PM

Mustang Bio Receives Nasdaq Delisting Notice for Bid Price

AI Summary

Mustang Bio, Inc. received a notice from Nasdaq on April 15, 2026, indicating non-compliance with the minimum bid price requirement. The company's common stock traded below $1.00 per share for 30 consecutive business days. Mustang Bio has been granted a 180-calendar day grace period, until October 12, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of ten consecutive business days.

Key Highlights

  • Received Nasdaq notice on April 15, 2026, for bid price below $1.00.
  • Stock closed below $1.00 for 30 consecutive business days.
  • Granted 180-calendar day grace period until October 12, 2026.
  • Must maintain $1.00 bid price for 10-20 consecutive business days to regain compliance.
MBIO
Biotechnology: Pharmaceutical Preparations
MUSTANG BIO, INC.

Price Impact